Publication | Open Access
Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw
42
Citations
11
References
2018
Year
Bone DiseaseZoledronic AcidBone HealthOrthopaedic SurgeryOsteoarthritisMaxillofacial SurgeryRisk FactorSurgeryMedicineOsteoporosisBone MetabolismHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1